Credential Qtrade Securities Inc. Amgen Inc Transaction History

Credential Qtrade Securities Inc.

$1.86 Trillion
Q1 2024

A detailed history of Credential Qtrade Securities Inc. transactions in Amgen Inc stock. As of the latest transaction made, Credential Qtrade Securities Inc. holds 4,088 shares of AMGN stock, worth $1.25 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

4,088

Previous 4,015 1.82%

Holding current value

$1.25 Million

Previous $1.16 Billion 0.51%

% of portfolio

0.06%

Previous 0.07%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jul 21, 2025	BUY	$268.87 - $324.56 $19,627 - $23,692	73 Added 1.82%	4,088 $1.16 Billion
Q4 2023 Jul 21, 2025	SELL	$255.7 - $288.46 $62,135 - $70,095	-243 Reduced 5.71%	4,015 $1.16 Billion
Q3 2023 Jul 21, 2025	SELL	$218.65 - $271.46 $27,768 - $34,475	-127 Reduced 2.9%	4,258 $1.14 Billion
Q2 2023 Jul 21, 2025	SELL	$214.27 - $253.37 $56,781 - $67,143	-265 Reduced 5.7%	4,385 $974 Million
Q1 2023 Jul 21, 2025	BUY	$225.79 - $275.2 $14,676 - $17,888	65 Added 1.42%	4,650 $1.12 Billion
Q4 2022 Jul 21, 2025	BUY	$229.03 - $291.01 $687 - $873	3 Added 0.07%	4,585 $1.2 Billion
Q3 2022 Jul 21, 2025	BUY	$224.46 - $253.15 $537,132 - $605,787	2,393 Added 109.32%	4,582 $1.03 Billion
Q2 2022 Jul 21, 2025	BUY	$230.71 - $256.74 $26,300 - $29,268	114 Added 5.49%	2,189 $533 Million
Q1 2022 Jul 21, 2025	BUY	$219.27 - $242.57 $30,697 - $33,959	140 Added 7.24%	2,075 $502 Million
Q4 2021 Jul 21, 2025	SELL	$198.88 - $227.6 $4,972 - $5,690	-25 Reduced 1.28%	1,935 $435 Million
Q3 2021 Jul 21, 2025	SELL	$212.27 - $248.7 $563,576 - $660,298	-2,655 Reduced 57.53%	1,960 $417 Million
Q2 2021 Jul 21, 2025	BUY	$233.58 - $259.14 $198,543 - $220,269	850 Added 22.58%	4,615 $1.12 Billion
Q1 2021 Jul 21, 2025	BUY	$221.91 - $258.6 $84,103 - $98,009	379 Added 11.19%	3,765 $937 Million
Q4 2020 Jul 21, 2025	BUY	$216.38 - $257.67 $173,969 - $207,166	804 Added 31.14%	3,386 $779 Million
Q3 2020 Jul 21, 2025	SELL	$234.65 - $260.95 $154,165 - $171,444	-657 Reduced 20.28%	2,582 $656 Million
Q2 2020 Jul 21, 2025	BUY	$197.81 - $242.74 $175,853 - $215,795	889 Added 37.83%	3,239 $764 Million
Q1 2020 Jul 21, 2025	BUY	$182.24 - $241.7 $40,275 - $53,415	221 Added 10.38%	2,350 $476 Million
Q4 2019 Jul 21, 2025	SELL	$189.21 - $243.2 $6,054 - $7,782	-32 Reduced 1.48%	2,129 $513 Million
Q3 2019 Jul 21, 2025	SELL	$174.11 - $208.62 $902,063 - $1.08 Million	-5,181 Reduced 70.57%	2,161 $418 Million
Q2 2019 Jul 21, 2025	BUY	$166.7 - $195.41 $507,434 - $594,828	3,044 Added 70.82%	7,342 $1.35 Billion
Q1 2019 Jul 21, 2025	SELL	$180.87 - $203.88 $13,565 - $15,291	-75 Reduced 1.72%	4,298 $817 Million
Q4 2018 Jul 21, 2025	BUY	$178.4 - $208.25 $376,780 - $439,824	2,112 Added 93.41%	4,373 $852 Million
Q3 2018 Jul 21, 2025	BUY	$185.29 - $208.89 $418,940 - $472,300	2,261 New	2,261 $469 Million

Others Institutions Holding AMGN

# of Institutions

3,285

Shares Held

426M

Call Options Held

8.07M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $164B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credential Qtrade Securities Inc., based on Form 13F filings with the SEC.

News

Stay updated on Credential Qtrade Securities Inc. with notifications on news.

Account

Credential Qtrade Securities Inc. Amgen Inc Transaction History